3 months ago
PEN
AnalystsDavid RescottDavid Rescott's Stock Forecasts
AnalystsDavid Rescott
Sectors:
Analyst Ranking
Top 22%
#1073 out of 5077 analysts
Average Return
+6.79%
Win Rate
55%35 out of 64
Risk vs Reward
Poor
Good
David Rescott's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Penumbra IncPEN | +141.93% | $124.98 | $302.36 | 2022-07-19 - 2023-07-19 | Strong Buy |
Inari Medical IncNARI | +70.64% | $46.56 | $79.45 | 2024-07-30 - 2025-01-07 | Buy |
Si Bone IncSIBN | +65.40% | $12.08 | $19.98 | 2022-12-19 - 2023-12-19 | Strong Buy |
Inari Medical IncNARI | +61.55% | $49.18 | $79.45 | 2024-10-28 - 2025-01-07 | Buy |
Boston Scientific CorpBSX | +55.49% | $53.97 | $83.92 | 2023-09-20 - 2024-09-20 | Buy |
David Rescott Analyst Color
Get additional color on David Rescott's coverage of popular stocks
3 months ago
PEN
6 months ago
PEN
8 months ago
PEN
2 years ago
SIBN
2 years ago
PEN
2 years ago
AXNX
2 years ago
PEN
David Rescott's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Si Bone IncSIBN | 6 | Strong Buy | $20.00 | +29.12% | Maintains | 11 days ago |
Boston Scientific CorpBSX | 9 | Buy | $128.00 | +26.59% | Maintains | 25 days ago |
Medtronic PLCMDT | 7 | Hold | $96.00 | +2.49% | Maintains | 2 months ago |
Penumbra IncPEN | 30 | Strong Buy | $310.00 | +22.53% | Maintains | 3 months ago |
Edwards Lifesciences CorpEW | 5 | Hold | $79.00 | +3.81% | Maintains | 3 months ago |
Haemonetics CorpHAE | 1 | Buy | $87.00 | +69.72% | Initiates Coverage On | 4 months ago |
Livanova PLCLIVN | 3 | Buy | $61.00 | +11.13% | Maintains | 6 months ago |
Merit Medical Systems IncMMSI | 3 | Buy | $110.00 | +32.95% | Maintains | 6 months ago |
Intuitive Surgical IncISRG | 3 | Buy | $575.00 | +5.21% | Maintains | 6 months ago |
Inari Medical IncNARI | 4 | Hold | $80.00 | +0.04% | Downgrades | 10 months ago |
Axonics IncAXNX | 8 | Hold | $71.00 | N/A | Downgrades | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.